RWS and Kayentis join forces to improve data confidence in neuroscience clinical trials
Industry’s best-in-class eCOA and expert rater training launches to reduce variability and improve CNS clinical trial data
Maidenhead, UK
4/15/2026 9:00:00 AM
4/15/2026 9:00:00 AM
RWS (RWS.L), a global AI solutions company, and Kayentis, a global leader in electronic Clinical Outcome Assessment (eCOA), today announce a partnership combining RWS’s rater training service with Kayentis’ robust eCOA platform.
This coordinated approach reduces variability in clinician assessments, enabling improved quality and reliability of Clinician-Reported Outcomes (ClinRO) in clinical trials, notably in Central Nervous System (CNS) studies that are complex.
Long study durations, intricate assessment scales and particularly vulnerable patient populations in CNS trials increase the risk of inconsistent data.
This collaboration solves one of the biggest challenges in neuroscience research: variability in clinician assessments, where even small inconsistencies in scoring or scale administration can affect endpoint reliability and, ultimately, the validity of trial results.
By combining Kayentis’ flexible eCOA platform with RWS’s specialist rater training, the partnership aims at helping sponsors and contract research organizations (CROs) reduce variability at both the human and technology levels.
“Our CNS rater training service was built to tackle one of the biggest risks in neuroscience trials: inconsistent clinician assessments. Working with Kayentis allows us to connect that expertise directly to how data is captured in real-world trial environments.”
Clinical assessment improvements
The joint solution integrates training, certification and data capture into a single, quality-driven workflow across the full trial lifecycle. It includes:
- Specialist rater training, including qualification, certification and ongoing monitoring tailored to specific indications and assessment scales
- Advanced eCOA technology, designed for complex ClinRO administration and adaptable to real-world site conditions
- Integrated access controls, ensuring only certified clinicians can complete specific assessments, reducing the risk of unqualified or out-of-date raters
Together, these capabilities help improve consistency across sites, strengthen endpoint reliability and support inspection-ready datasets.
“Capturing data digitally isn’t enough, sponsors need data they can trust. By aligning rater qualification with purpose-built eCOA workflows, we help reduce variability and give teams greater confidence in their results. This partnership with RWS brings a more coordinated approach, aligning how clinicians are trained, certified and monitored with how data is captured and controlled.”
Designed for complex, global trials
The partnership offers a more streamlined model for sponsors and CROs managing complex studies. By aligning workflows and simplifying vendor management, it reduces operational burden while maintaining high standards of data quality.
The partnership formalizes a long-standing collaboration between the two organizations and reflects recent investment on both sides. RWS has recently expanded its CNS offering with dedicated rater training services, while Kayentis has enhanced its Clin’form platform and strengthened its scientific advisory board with neuroscience expertise.
The joint solution is available immediately for sponsors and CROs running CNS and other complex trials requiring high-quality ClinRO data from study start through closeout.